The weekly litigation news digest is live. Subscribe now

IP Verse

S1P Receptor Modulators For Treating Multiple Sclerosis - EP2959894

The patent EP2959894 was granted to Novartis on Oct 12, 2022. The application was originally filed on Jun 25, 2007 under application number EP15177166A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2959894

NOVARTIS
Application Number
EP15177166A
Filing Date
Jun 25, 2007
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (23)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELJul 12, 2023MAIWALDWITHDRAWN
GENERIS FARMACEUTICAJul 12, 2023-WITHDRAWN
ADAMED PHARMAJul 11, 2023VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBWITHDRAWN
EGISJul 11, 2023STOLMAR & PARTNERWITHDRAWN
SYNTHONMay 22, 2023HAMM & WITTKOPPWITHDRAWN
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 10, 2023SONNENHAUSERWITHDRAWN
NEURAXPHARM ARZNEIMITTELMar 22, 2023ZBM PATENTS ZEAWITHDRAWN
DR SCHONJan 23, 2023DR SCHONWITHDRAWN
BIOGARANJan 13, 2023CASALONGAWITHDRAWN
STADA ARZNEIMITTELJan 9, 2023HAMM & WITTKOPPWITHDRAWN
BAUSCH HEALTH IRELANDJan 2, 2023MAIWALDWITHDRAWN
VIVANTA GENERICS SRO MSN LABRATORIES PRIVATEDec 6, 2022HAMM & WITTKOPPWITHDRAWN
HEUMANN PHARMA GENERICADec 5, 2022HAMM & WITTKOPPWITHDRAWN
ACCORD HEALTHCAREDec 1, 2022HOFFMANN EITLEWITHDRAWN
A MEDNov 21, 2022GREINERWITHDRAWN
RAFARMNov 9, 2022BECKER KURIG & PARTNER PATENTANWALTE MBBWITHDRAWN
GENEPHARMNov 4, 2022ROUKOUNASWITHDRAWN
ELPEN PHARMACEUTICALOct 20, 2022ROUKOUNASWITHDRAWN
GENERICS UKOct 12, 2022GILL JENNINGS & EVERYWITHDRAWN
GLENMARK PHARMACEUTICALS EUROPEOct 12, 2022JOHNSONWITHDRAWN
PHARMATHENOct 12, 2022LAUWITHDRAWN
TEVA PHARMACEUTICALSOct 12, 2022D YOUNGWITHDRAWN
ZENTIVA KSOct 12, 2022GREINERWITHDRAWN

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP1613288
OPPOSITIONEP2037906
OPPOSITIONEP2633864
OPPOSITIONEP2698154
OPPOSITIONEP2959864
OPPOSITIONEP2959894
OPPOSITIONGB612721
OPPOSITIONUS2006046979
OPPOSITIONWO03097028
OPPOSITIONWO03099192
OPPOSITIONWO2004050073
OPPOSITIONWO2004113330
OPPOSITIONWO2006058316
OPPOSITIONWO2007059188
OPPOSITIONWO2008000419
OTHEREP2037906
OTHEREP2698154
OTHEREP2959894
OTHEREP3797765
OTHERWO2006058316
OTHERWO2008000419
SEARCHUS2006046979
SEARCHWO03097028
SEARCHWO03099192
SEARCHWO2004050073
SEARCHWO2004113330
SEARCHWO2006058316

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents